{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:06:06Z","timestamp":1790960766421,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/TA\/0025\/2013"],"award-info":[{"award-number":["NMRC\/TA\/0025\/2013"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CG\/016\/2013"],"award-info":[{"award-number":["NMRC\/CG\/016\/2013"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["WS2347894"],"award-info":[{"award-number":["WS2347894"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3672-5","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T08:03:02Z","timestamp":1547712182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Molecular mechanisms of azole resistance in Candida bloodstream isolates"],"prefix":"10.1186","volume":"19","author":[{"given":"Jocelyn Qi-Min","family":"Teo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon Jing-Yi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Ling","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn Su-May","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze-Peng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8981-4411","authenticated-orcid":false,"given":"Andrea Lay-Hoon","family":"Kwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"key":"3672_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13756-017-0184-1","volume":"6","author":"JQ Teo","year":"2017","unstructured":"Teo JQ, Candra SR, Lee SJ, Chia SY, Leck H, Tan AL, Neo HP, Leow KW, Cai Y, Ee RP, et al. Candidemia in a major regional tertiary referral hospital - epidemiology, practice patterns and outcomes. Antimicrob Resist Infect Control. 2017;6:27.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"9","key":"3672_CR2","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1128\/AAC.00027-12","volume":"56","author":"RK Shields","year":"2012","unstructured":"Shields RK, Nguyen MH, Press EG, Kwa AL, Cheng S, Du C, Clancy CJ. The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata. Antimicrob Agents Chemother. 2012;56(9):4862\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"3672_CR3","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement. CLSI document M27-S4","author":"CLSI","year":"2012","unstructured":"CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement. CLSI document M27-S4. Wayne: Clinical and Laboratory Standards Institute; 2012."},{"issue":"8","key":"3672_CR4","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1128\/JCM.01230-13","volume":"51","author":"E Canton","year":"2013","unstructured":"Canton E, Peman J, Iniguez C, Hervas D, Lopez-Hontangas JL, Pina-Vaz C, Camarena JJ, Campos-Herrero I, Garcia-Garcia I, Garcia-Tapia AM, et al. Epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole for six Candida species as determined by the colorimetric Sensititre YeastOne method. J Clin Microbiol. 2013;51(8):2691\u20135.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"3672_CR5","doi-asserted-by":"publisher","first-page":"4608","DOI":"10.1128\/AAC.49.11.4608-4615.2005","volume":"49","author":"P Vandeputte","year":"2005","unstructured":"Vandeputte P, Larcher G, Berges T, Renier G, Chabasse D, Bouchara JP. Mechanisms of azole resistance in a clinical isolate of Candida tropicalis. Antimicrob Agents Chemother. 2005;49(11):4608\u201315.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"3672_CR6","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1128\/AAC.48.6.2124-2131.2004","volume":"48","author":"AS Chau","year":"2004","unstructured":"Chau AS, Mendrick CA, Sabatelli FJ, Loebenberg D, McNicholas PM. Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles. Antimicrob Agents Chemother. 2004;48(6):2124\u201331.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3672_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/myc.12439","volume":"59","author":"A Mane","year":"2016","unstructured":"Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, Risbud A. Molecular mechanisms associated with fluconazole resistance in clinical Candida albicans isolates from India. Mycoses. 2016;59(2):93\u2013100.","journal-title":"Mycoses"},{"issue":"4","key":"3672_CR8","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/jac\/dks481","volume":"68","author":"C Jiang","year":"2013","unstructured":"Jiang C, Dong D, Yu B, Cai G, Wang X, Ji Y, Peng Y. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. J Antimicrob Chemother. 2013;68(4):778\u201385.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"3672_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1128\/EC.00073-10","volume":"10","author":"KE Caudle","year":"2011","unstructured":"Caudle KE, Barker KS, Wiederhold NP, Xu L, Homayouni R, Rogers PD. Genomewide expression profile analysis of the Candida glabrata Pdr1 regulon. Eukaryot Cell. 2011;10(3):373\u201383.","journal-title":"Eukaryot Cell"},{"key":"3672_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2199-13-22","volume":"13","author":"QQ Li","year":"2012","unstructured":"Li QQ, Skinner J, Bennett JE. Evaluation of reference genes for real-time quantitative PCR studies in Candida glabrata following azole treatment. BMC Mol Biol. 2012;13:22.","journal-title":"BMC Mol Biol"},{"issue":"2","key":"3672_CR11","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/147323001003800216","volume":"38","author":"LM Chen","year":"2010","unstructured":"Chen LM, Xu YH, Zhou CL, Zhao J, Li CY, Wang R. Overexpression of CDR1 and CDR2 genes plays an important role in fluconazole resistance in Candida albicans with G487T and T916C mutations. J Int Med Res. 2010;38(2):536\u201345.","journal-title":"J Int Med Res"},{"issue":"10","key":"3672_CR12","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1128\/AAC.44.10.2693-2700.2000","volume":"44","author":"KW Henry","year":"2000","unstructured":"Henry KW, Nickels JT, Edlind TD. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother. 2000;44(10):2693\u2013700.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3672_CR13","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1128\/AAC.49.2.668-679.2005","volume":"49","author":"M Sanguinetti","year":"2005","unstructured":"Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chemother. 2005;49(2):668\u201379.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"3672_CR14","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1128\/AAC.00555-13","volume":"57","author":"J Eddouzi","year":"2013","unstructured":"Eddouzi J, Parker JE, Vale-Silva LA, Coste A, Ischer F, Kelly S, Manai M, Sanglard D. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals. Antimicrob Agents Chemother. 2013;57(7):3182\u201393.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3672_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.myc.2016.11.001","volume":"58","author":"KL Chew","year":"2017","unstructured":"Chew KL, Cheng JWS, Jureen R, Lin RTP, Teo JWP. ERG11 mutations are associated with high-level azole resistance in clinical Candida tropicalis isolates, a Singapore study. Mycoscience. 2017;58(2):111\u20135.","journal-title":"Mycoscience"},{"key":"3672_CR16","doi-asserted-by":"publisher","unstructured":"Fan X, Xiao M, Zhang D, Huang JJ, Wang H, Hou X, Zhang L, Kong F, Chen SC, Tong ZH, et al. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China. Clin Microbiol Infect. 2018. \n                    https:\/\/doi.org\/10.1016\/j.cmi.2018.11.007\n                    \n                  . Epub ahead of print.","DOI":"10.1016\/j.cmi.2018.11.007"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3672-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3672-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3672-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T19:07:05Z","timestamp":1579201625000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3672-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3672"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3672-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,17]]},"assertion":[{"value":"5 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research protocol was approved by the Singhealth Centralised Institutional Review Board (2013\/987\/D). Informed consent was waived in view of retrospective nature of study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"63"}}